Literature DB >> 164116

Limits of applicability of the firefly luminescence ATP assay for the detection of bacteria in clinical specimens.

R B Conn, P Charache, E W Chappelle.   

Abstract

ATP measurement can be used as an indicator of biological mass, and the extreme sensitivity of the firefly ATP assay has led to its use in bacterial detection systems. Clinical specimens present problems not encountered with cultured isolates of known bacterial species. The lower limit of sensitivity for detecting bacteria using the firefly assay is 100,000 bacteria per ml. Non-bacterial ATP, which is probably present in all clinical specimens, produces false-positive results unless it is completely destroyed, and this destruction must be carried out under conditions that do not affect bacterial ATP. A cause of false-negative results is the presence in all urine specimens of unidentified materials that inhibit the luminescent enzymic reaction. These considerations indicate that application of the firefly ATP assay in bacterial detection systems for clinical specimens is feasible only if a preparatory step separates bacteria from interfering materials and from non-bacterial sources of ATP, and concentrates microorganisms to measurable levels. These limitations sharply curtain the applicability in diagnostic microbiology of this exotic chemical reaction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164116     DOI: 10.1093/ajcp/63.4.493

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  15 in total

1.  Reliability of a bioluminescence ATP assay for detection of bacteria.

Authors:  L Selan; F Berlutti; C Passariello; M C Thaller; G Renzini
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

2.  Rapid antimicrobial susceptibility determination of uropathogens in clinical urine specimens by use of ATP bioluminescence.

Authors:  Vesna Ivancic; Mitra Mastali; Neil Percy; Jeffrey Gornbein; Jane T Babbitt; Yang Li; Elliot M Landaw; David A Bruckner; Bernard M Churchill; David A Haake
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

3.  Comparison of the standard pour plate procedure and the ATP and Limulus amebocyte lysate procedures for the detection of microbial contamination in intravenous fluids.

Authors:  R L Anderson; A K Highsmith; B W Holland
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

4.  Rapid detection of bacterial growth in blood cultures by bioluminescent assay of bacterial ATP.

Authors:  O Molin; L Nilsson; S Anséhn
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

5.  Clinical laboratory evaluation of a urine screening device.

Authors:  M A Pfaller; C A Baum; A C Niles; P R Murray
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

6.  Bioluminescence screening for bacteriuria.

Authors:  J C Kolbeck; R A Padgett; E G Estevez; L J Harrell
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

7.  Firefly luciferase ATP assay as a screening method for bacteriuria.

Authors:  A Thore; A Lundin; S Anséhn
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

8.  Comparison of the Lumac and Monolight systems for detection of bacteriuria by bioluminescence.

Authors:  D L Drow; C H Baum; G Hirschfield
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

9.  Analysis of the disagreement between automated bioluminescence-based and culture methods for detecting significant bacteriuria, with proposals for standardizing evaluations of bacteriuria detection methods.

Authors:  W W Nichols; G D Curtis; H H Johnston
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

10.  ATP measurements obtained by luminometry provide rapid estimation of Ureaplasma urealyticum growth.

Authors:  M E Stemler; G W Stemke; J A Robertson
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.